Allogene stock forecast
WebFeb 27, 2024 · Allogene Therapeutics (ALLO) stock forecast for 2026 Last update: February 27, 2024 (12:50) Sector: Healthcare The share price of Allogene Therapeutics, Inc. (ALLO) now What analysts predict: $22.69 52-week High/Low: $17.49 / $5.41 50/200 Day Moving Average: $6.86 / $10.19 This figure corresponds to the Average Price over … WebMar 10, 2024 · Allogene Therapeutics, Inc. Common Stock (ALLO) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
Allogene stock forecast
Did you know?
WebALLO Stock 12 Months Forecast. $17.46. (218.03% Upside) Based on 14 Wall Street analysts offering 12 month price targets for Allogene Therapeutics in the last 3 months. … Web1 day ago · The Price to Free Cash Flow ratio or P/FCF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator ...
WebOct 19, 2024 · The possible outcomes for Allogene are on two extreme sides (Table II). It’s possible that the FDA’s investigation will reveal the chromosomal abnormality is not a concern and quickly restart the... WebA. While ratings are subjective and will change, the latest Allogene Therapeutics ( ALLO) rating was a maintained with a price target of $29.00 to $23.00. The current price Allogene Therapeutics ...
WebApr 4, 2024 · Allogene Therapeutics's earnings is forecast to decline at an annual rate of 3.9% and its revenue is expected to decline at 60.5% annually. EPS and ROE are … WebThe average Allogene Therapeutics stock forecast 2024 represents a 37.04% increase from the last price of $4.8899998664856. For Allogene Therapeutics stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Allogene Therapeutics stock forecast of $5.53, a high forecast of $6.46, and a low forecast of …
WebWhat are analysts forecasts for Allogene Therapeutics stock? The 22 analysts offering price forecasts for Allogene Therapeutics have a median target of 22.59, with a high estimate of 45.00 and a ...
Web2 days ago · SOUTH SAN FRANCISCO, Calif., April 13, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company … tenis puma batman neymarWebApr 9, 2024 · 13 analysts have issued 1 year price objectives for Allogene Therapeutics' stock. Their ALLO share price forecasts range from $6.00 to $31.00. On average, they … tenis puma bmw 2021Web11 hours ago · Teva Pharmaceutical Industries Ltd. (TEVA) : Free Stock Analysis Report. Kala Pharmaceuticals, Inc. (KALA) : Free Stock Analysis Report. Allogene Therapeutics, Inc. (ALLO) : Free Stock Analysis Report tenis puma bmw 2022WebApr 12, 2024 · Allogene Therapeutics stock was originally listed at a price of $25.00 in Oct 11, 2024. If you had invested in Allogene Therapeutics stock at $25.00, your return over … tenis puma bmw mmsWebAllogene Therapeutics stock forecast for 2024 by month. Technical analysis, historical chart. Tables. Target levels, support and resistance levels. tenis puma bebeWebMar 22, 2024 · Allogene Therapeutics Inc. (NASDAQ:ALLO)’s beta value is currently sitting at 0.81, while the Average True Range indicator is currently displaying 0.36. With analysts defining $6.00-$35.00 as the low and high price targets, we arrive at a consensus price target of $16.69 for the trailing 12-month period. tenis puma bmwWebJan 15, 2024 · Allogene Therapeutics (ALLO) Forecast for 2026 After collecting analyst forecasts for Allogene Therapeutics stock for 2026, we made one consensus forecast. … tenis puma bmw mujer